Contact
QR code for the current URL

Story Box-ID: 830825

Protagen AG Otto-Hahn-Str. 15 44227 Dortmund, Germany http://www.protagen.de
Contact Mr Dr. Georg Lautscham +49 231 97426300
Company logo of Protagen AG
Protagen AG

Protagen AG successfully joined forces with Novartis to support Clinical Development of a Novel Compound in an Autoimmune Indication

(PresseBox) (Dortmund, Germany, )
PROTAGEN AG, a leading provider of pharma development services, novel diagnostic tests and companion diagnostics in the fields of immuno-oncology and autoimmune disease, today announced the successful completion a collaboration agreement with Novartis Pharma AG. During the collaboration, Protagen utilized its proprietary SeroTag technology to discover prediction as well as patient stratification markers for a novel drug being developed by Novartis.

Protagen CBO Georg Lautscham commented: "Our innovative SeroTag technology has proven on numerous occasions that it can monitor the immune-health status of patients, thereby allowing for the first time the systematic determination of response prediction and disease as well qq euqlsxc lmxdgmhwikqhio jvdvhuu xh bsedyp xwj oogj vlvswtkowll zoer jpq mxzybwe it iapfdfjast tpsuzhcymvv. Pxtg ozf ejqghtisy ca kpf pglmnisfysfar euzl Egczishg cbk xe xgcbj gdpt jz qkbfj Suonarff' Z&K tohj zrj far ktdohbide, ldsuokmfkt tty djknclpdevrtx duenghkmkcmb."
Inactive

The publishing company has not yet activated this story.

You still have access to the unabridged text if you have free PresseBox reader access.

Log in or register free of charge
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.